Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06103682
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:30.094290+00:00
Published At
2023-10-31T00:00:00+00:00
Record Updated At
2023-10-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-small Cell Lung Cancer", "Oligoprogressive", "Small-cell Lung Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-31"
protocolSection.identificationModule.nctId
"NCT06103682"
protocolSection.identificationModule.officialTitle
"LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Oligoprogressive (protocolSection.conditionsModule.conditions)
  • Small-cell Lung Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.